Fever occurs upon binding of prostaglandin E2 (PGE2) to EP3 receptors in the median preoptic nucleus of the hypothalamus, but the origin of the pyrogenic PGE2 has not been clearly determined. Here, using mice of both sexes, we examined the role of local vs generalized PGE2 production in the brain for the febrile response. In wild-type mice and in mice with genetic deletion of the prostaglandin synthesizing enzyme cyclooxygenase-2 in the brain endothelium, generated with an inducible CreER T2 under the Slco1c1 promoter, PGE2 levels in the cerebrospinal fluid were only weakly related to the magnitude of the febrile response, whereas the PGE2 synthesizing capacity in the hypothalamus, as reflected in the levels of cyclooxygenase-2 mRNA, showed strong correlation with the immune-induced fever. Histological analysis showed that deletion of cyclooxygenase-2 in brain endothelial cells occurred preferentially in small and medium-sized vessels deep in the brain parenchyma, such as in the hypothalamus, whereas larger vessels, and particularly those close to the neocortical surface and in the meninges, were left unaffected, hence leaving PGE2 synthesis largely intact in major parts of the brain, while significantly reducing it in the region critical for the febrile response. Furthermore, injection of a virus vector expressing microsomal prostaglandin E synthase-1 (mPGES-1) into the median preoptic nucleus of fever-refractive mPGES-1 knock-out mice, resulted in a temperature elevation in response to LPS. We conclude that the febrile response is dependent on local release of PGE2 onto its target neurons and not on the overall PGE2 production in the brain.
Introduction
It is now well established that prostaglandin E2 (PGE2) is the final mediator of inflammationinduced fever (Li et al., 1999; Engblom et al., 2003) . Fever has long been associated with elevated brain levels of PGE2 (Splawinski, 1977) ; in response to a peripheral immune stimulus, PGE2 levels in the cerebrospinal fluid increase concomitant with the febrile response (Inoue et al., 2002) , and injection of PGE2 into the cerebrospinal fluid elicits fever in a dose-dependent way (Nilsberth et al., 2009b) . PGE2 is synthesized by brain endothelial cells through the concerted action of the inducible enzymes cyclooxygenase (Cox)-2 and microsomal prostaglandin E synthase-1 (mPGES-1) (Ek et al., 2001; Yamagata et al., 2001 ).
These correlational studies have later been complemented by functional genetic studies, which have shown that genetic deletion of Cox-2 or mPGES-1 in the brain endothelium strongly attenuates the febrile response (Wilhelms et al., 2014) , hence demonstrating that the brain endothelium plays a critical role for the generation of the PGE2 that is seen in the brain during fever.
Because a peripheral immune stimulus elicits the induction of prostaglandin synthesizing enzymes throughout the brain vasculature (Ek et al., 2001; Yamagata et al., 2001) , suggesting a generalized PGE2 release, the specificity of the PGE2 elicited responses comes about through the distinct distribution of its receptor subtypes (Zhang and Rivest, 1999; Ek et al., 2000; Oka et al., 2000) , as demonstrated by the attenuation of fever through deletion of EP3 receptors in the median preoptic nucleus, but not by deletion of these receptors at other sites (Lazarus et al., 2007) . However, it is less clear whether the responses evoked by PGE2 binding to its receptors is the result of PGE2 release locally, in a paracrine fashion, or if PGE2 released at other sites also can elicit fever under physiological conditions (Matsumura et al., 1997) . Whereas studies using injections of PGE2 or cyclooxygenase inhibitors support the importance of local synthesis (Scammell et al., 1996; Scammell et al., 1998) , the critical site of prostaglandin synthesis has not been investigated using modern functional genetic techniques. Here we addressed this question by examining in normal mice and in mice with deletion of Cox-2 in the brain endothelium the relationship between the magnitude of the febrile response to a peripheral immune stimulus and the level of induced PGE2 in the cerebrospinal fluid, as seen in individual animals. We also examined the relationship between the magnitude of the febrile response and the level of Cox-2 mRNA in the hypothalamus, as well as the PGE2 levels in plasma, and we determined by using immunohistochemistry how Cox-2 expression in different types of vessels was related to the febrile response. Finally, we examined if local endogenous immune-induced production of PGE2 in the anterior hypothalamus resulted in a temperature response. Our data show that local PGE2 release onto brain PGE2 receptors is the mechanism governing the febrile response to peripheral immune challenge.
Materials and Methods

Animals
Mice with specific deletion of Cox-2 in brain endothelial cells were generated by crossing animals in which exons 4-5 of the Cox-2 gene (Ptgs2) are flanked by loxP-sites (Ishikawa and Herschman, 2006) with animals expressing a tamoxifen inducible CreER T2 under the Slco1c1 promoter [expressed in the cerebrovascular endothelium (Ridder et al., 2011) ]. The tamoxifen (Sigma-Aldrich, St. Louis, MO; 1 mg diluted in a mixture of 10 % ethanol and 90 % sunflower seed oil) was injected intraperitoneally (ip; 0.1 ml) twice a day for five days, followed by a five week recovery period before any further experiments were done. The inducible Cre-line was also crossed with a Cre reporter line, which expresses a Gt(ROSA)26Sor locus with a loxP-flanked STOP cassette preventing transcription of a CAG promoter-driven red fluorescent protein variant (tdTomato) (Jackson Laboratory, Bar Harbor, ME; RRID: IMSR_JAX:007914), and the offspring was treated with tamoxifen as above.
Mice with deletion of the Ptges gene (Trebino et al., 2003) , encoding mPGES-1, were from our own breeding and on a C57B/6 background. All animal experiments were approved by the local Animal Care and Use Committee and followed international guidelines.
Telemetric temperature recordings
The mice were briefly anesthetized with isoflurane (Abbot Scandinavia, Solna, Sweden) and implanted ip with a transponder that records core body temperature (Mini Mitter, Bend, OR).
Immediately after surgery, the mice were transferred to a room in which the ambient temperature was set to 29°C, providing near-thermoneutral conditions (Rudaya et al., 2005) .
Injection of lentiviral vectors
Mice were anesthetized with isoflurane and mounted onto a stereotaxic frame. The scalp was exposed and two small drill holes were made at the level of the Bregma, on each side of the midline. A Hamilton syringe was lowered to a position that in relation to Bregma was 0.0 mm anteroposteriorly, 0.3 mm mediolaterally, and 5.5 mm dorsoventrally. A lentiviral vector was then injected at a rate of 180 nl/min during 3 min. The syringe remained in place for at least 3 min after the infusion and was then slowly removed, after which the skin was closed. Mice were injected either with a lentiviral vector, in Dulbecco's phosphate-buffered saline containing MgCl2 and CaCl2 (Sigma-Aldrich; catalogue # D8662), expressing GFP [lenti-5-KP-pgk-GFP; 5 x 10 8 -1 x 10 9 TU/ml, produced as previously described (Zufferey et al., 1997; Georgievska et al., 2004) ; a gift from Johan Jakobsson, Lund, Sweden], or a lentiviral vector expressing human mPGES-1 (suCMV promoter -human Ptges (NM_004878) -Rsv promoter -puromycin resistance; 10 8 IFU/ml; AMS Biotechnology, Abingdon, UK), to which was added 10 % of the lenti-GFP virus to permit subsequent immunofluorescent identification of the injection site (we found no available antibody that could detect mPGES-1). During the same surgical session, a temperature transponder was implanted in the abdominal cavity, as described above.
Immune stimulation
Mice were injected ip with bacterial wall lipopolysaccharide (LPS) from Escherichia coli (Sigma-Aldrich; O111:B4; 120 µg/kg body weight, diluted in 100 µl), 1 week or 3 weeks (virus injected mice) following implantation of the temperature transponder.
Tissue collection
Mice injected with LPS only were killed 5 h after injection [This time point was selected since it corresponds to the time of peak fever in this experimental paradigm (e.g., Hamzic et al., 2013) ]. Blood was drawn from the right atrium, transferred to EDTA-coated tubes (Sarstedt, Landskrona, Sweden) to which were added indomethacin (10 μM; Sigma-Aldrich),
and centrifuged at 7000 × g for 7 min at 4°C. The plasma was immediately frozen on dry ice and kept at −70°C. The animals were then placed in a stereotaxic frame, the atlanto-occipital membrane was exposed, and cerebrospinal fluid (CSF) withdrawn from the cisterna magna using a Hamilton syringe mounted on a micromanipulator and immediately frozen. Samples that contained traces of blood were discarded. The whole procedure from when the animals were killed until CSF was withdrawn took less than 10 min. A hypothalamic block was then dissected and placed in RNAlater stabilization reagent (Qiagen, Hilden, Germany) and stored at −70°C until analysis. This block was first isolated by two coronal cuts, one placed 0.5 mm rostral to the apex of the optic chiasm and the other at the caudal margin of the mammillary bodies. The resulting slab was then trimmed by sagittal cuts on each side through the sulcus between the hypothalamus and the temporal lobe. Finally, a horizontal cut was placed slightly above the anterior commissure. Mice injected with viral vectors were killed the day after the immune challenge with LPS. After asphyxiation with CO2 one group of mice were fixed by transcardial perfusion with a phosphate-buffered (0.1 M) paraformaldehyde solution (4 %).
The brains were removed and post-fixed for 3 h in the same fixative and then cryoprotected with 25 % sucrose in phosphate-buffered saline (PBS). In another groups of mice the brain was immediately removed. The hypothalamus was dissected and stored in RNAlater (Qiagen)
at −70 °C.
Immunohistochemistry
Brains were cut in the frontal plane at 30 µm on a freezing microtome. The immunohistochemical procedures were carried out according to standardized protocols (Engström et al., 2012) . In brief, sections were incubated in a blocking solution [PBS 
Assays for PGE2 levels in CSF and plasma
The concentration of PGE2 in CSF (diluted 1:100) was determined using a High Sensitivity Prostaglandin E2 Enzyme Immunoassay Kit (Assay Designs, Ann Arbor, MI). The values were calculated using a standard curve ranging from 7.81-1000 pg/ml (R 2 = 1). The kit antiserum shows the following cross-reactivity, according to the manufacturer: PGE2 100 %, PGE1 70 %, PGE3 16.3 %, PGF1α 1.4 %, PGF2α 0.7 %, 6-keto-PGF1α 0.6 %, PGA2 0.1 %, PGB1 0.1 %, and < 0.1 % for 13,14-dihydro-15-keto-PGF2α, 6, 15-keto, 13, 4-dihydro-PGF1α, thromboxane B2, 2 arachidonoylglyerol, anandamide, PGD2 and arachidonic acid.
The concentration of PGE2 metabolites in plasma was determined with a Prostaglandin E Metabolite EIA Kit (Cayman Chemical, Ann Arbor, MI). The values were calculated using a standard curve ranging from 0.2-50 pg/ml (R 2 = 0.999). The kit antiserum recognizes derivatized 13, 14-dihydro-15-ketoPGE1 and 13,14-dihydro-15-ketoPGE2, and bicycloPGE1, but has less than 0.01 % cross-reactivity with arachidonic acid, leukotriene B4, tetranor-PGEM, tetranor-PGFM, PGD2 , PGE1 , 6-keto PGE1, PGE2 , PGF1α , 6-keto PGF1α , PGF2α and thromboxane B2.
Real time quantitative PCR analyses (qPCR)
RNA was extracted with RNeasy Universal Plus kit or RNeasy Micro Kit (Qiagen) and reverse transcription was done with High Capacity cDNA Reverse Transcription kit (Applied Biosystems; Foster City, CA). qPCR was then performed using Gene Expression Master Mix (Applied Biosystems) on a 96-well plate (7900HT Fast RT-PCR system; Applied Biosystems). Assays used (from Applied Biosystems) were: Ptgs2: Mm00478374_m1;
human Ptges (Hs01115r610_m1), and Gapdh (Mm99999915_g1).
Experimental design and statistical analysis
For all comparisons between genotypes, littermates were used. Mice were of both sexes, and experimental groups balanced with respect to sex and age. Sample size is reported in the figure legends. All statistical analyses were done in Graph Pad Prism (GraphPad Software, La Jolla, CA). Analysis of differences in body temperature at 5 h between LPS-treated WT mice and mice with endothelial specific deletion of Cox-2 was done with a 1-way ANOVA followed by Sidak's multiple comparisons test. The same analysis was used for differences between groups with respect to PGE2 in CSF, and qPCR data. For PGE2 metabolites in plasma non-parametric statistics were used (Kruskal-Wallis test followed by Dunn's multiple comparisons test). Temperature responses after injections of viral vectors were analyzed with a 2-way repeated measures ANOVA followed by Tukey's post hoc test. Regression analysis was done with F-statistics. Qualitative data were analyzed with Fisher's exact test. Results were considered significant when P < 0.05.
Results
Deletion of Cox-2 in brain endothelial cells results in attenuated fever response to LPS
As reported previously (Wilhelms et al., 2014) 
No difference in PGE2 levels in CSF between Cox-2 ΔSlco1c1 mice and WT mice
We next examined if the difference in the febrile response to LPS between Cox-2 ΔSlco1c1 mice and WT mice was associated with a difference in CSF levels of PGE2. LPS-treatment resulted in elevated levels of PGE2 in CSF at 5 h post-injection (F3,37 = 8.003, P < 0.003; LPS WT vs NaCl WT: P = 0.0005; LPS Cox-2 ΔSlco1c1 vs NaCl Cox-2
ΔSlco1c1
: P = 0.0198), but there was no difference between genotypes (Figure 2a ).
Lower levels of induced Cox-2 mRNA in the hypothalamus of Cox-2 ΔSlco1c1 mice
qPCR analysis of the levels of Cox-2 mRNA in the hypothalamus of Cox-2 ΔSlco1c1 mice and WT mice showed significantly lower induction following LPS in the gene deleted mice than in the WT mice (F3,39 = 21.78, P < 0.0001; LPS WT vs LPS Cox-2
ΔSlco1c1
: P = 0.0021; Figure   2b ). As expected, there was also a small (but statistically not significant) reduction of Cox-2 mRNA in the NaCl treated Cox-2 ΔSlco1c1 mice compared to the WT mice ( Figure 2b) .
No difference in PGE2 metabolites levels in plasma between Cox-2 ΔSlco1c1 mice and WT mice
To examine if the gene deletion in the Cox-2 ΔSlco1c1 mice, which should occur only in brain endothelial cells (Ridder et al., 2011) , had influenced prostaglandin synthesis peripherally, the levels of PGE2 metabolites in plasma were analyzed. This assay was chosen instead of direct measurement of PGE2 because PGE2 in plasma is difficult to measure reliably (Samuelsson et al., 1975) , since it is rapidly converted in vivo to its 13,14-dihydro-15-keto metabolite, with more than 90 % of circulating PGE2 being cleared by a single passage through the lungs (Hamberg and Samuelsson, 1971 : P = 0.0327), but there was no difference between the genotypes (Figure 2c ).
Body temperature following immune stimulation correlates with Cox-2 mRNA levels in the hypothalamus but not with PGE2 levels in CSF
To further examine the relationship between body temperature and central prostaglandin synthesis, we next performed a regression analysis of the individual temperatures and the levels of PGE2 in cerebrospinal fluid in Cox-2 ΔSlco1c1 mice and WT mice 5 h post LPS injection. As shown (Figure 3a) , there was only weak relationship between these two parameters (R 2 = 0.157, F1,23 = 4.292, P = 0.0497; Figure 3a ). In contrast, there was a strong correlation between temperature and Cox-2 mRNA in the hypothalamus (R 2 = 0.593, F1,22 = 32.01, P < 0.0001; Figure 3b ). There was also moderately strong relationship between body temperature and PGE2 metabolites in plasma (R 2 = 0.4310, F1,23 = 17.42, P = 0.0004; Figure   3c ).
The levels of PGE2 in CSF correlate only weakly with Cox-2 mRNA expression in the hypothalamus and not with levels of PGE2 metabolites in plasma
To examine what affects the PGE2 levels in CSF, regression analysis was performed for the relationship between PGE2 in CSF and Cox-2 mRNA expression in the hypothalamus of LPS treated mice (Figure 4a ) and PGE2 metabolites in plasma in these mice (Figure 4b ), respectively. PGE2 levels in CSF showed only a weak relationship with the Cox-2 mRNA expression in the hypothalamus (R 2 = 0.1783, F1,25 = 5.424, P = 0.0282; Figure 4a ). In the same vein, there was no significant relationship between PGE2 levels in CSF and the levels of PGE2 metabolites in plasma (R 2 = 0.1321, F1,24 = 3.654, P = 0.0679; Figure 4b ), indicating that they have different sources of origin.
The gene deletion in Cox-2ΔSlco1c1 mice mainly occurs in smaller vessels in the brain parenchyma but not in large vessels
Since the above data indicated that the gene deletion in Cox-2 ΔSlco1c1 mice preferentially affected induced prostaglandin synthesis in the hypothalamus, but not generally in the brain, we examined histologically where the gene deletion took place. We crossed the mice with the tamoxifen inducible CreER T2 under the Slco1c1 promoter with a Cre reporter line expressing a Gt(ROSA)26Sor locus with a loxP-flanked STOP cassette, which prevents transcription of a CAG promoter-driven red fluorescent protein variant (tdTomato). Following tamoxifen treatment of the offspring we subjected it to immune challenge with LPS. We found that Creinduced recombination occurred preferentially in small and medium-sized blood vessels; in the latter tdTomato staining was found to be co-localized with induced Cox-2 immunoreactivity in endothelial cells (Figures 5a, b) . In contrast, Cox-2 positive cells in larger blood vessels rarely expressed tdTomato staining (Figure 5b, c) . We also examined brains from Cox-2 ΔSlco1c1 mice and WT mice for the co-expression of Cox-2 and lipocalin-2 immunoreactivity, in order to evaluate if the endothelial cells had responded to LPS, since lipocalin-2 is expressed in endothelial cells in response to LPS together with, but independently of Cox-2 (Hamzic et al., 2013; Vasilache et al., 2015) . We found that lipocalin-2 expressing cells in larger vessels, and in particular in vessels close to the surface of the neocortex, co-expressed Cox-2 extensively in both genotypes (Figures 6a, b) . Strong
Cox-2 labeling was also seen among lipocalin-2 expressing cells in meningeal vessel in both genotypes (Figures 6c, d) . However, smaller vessels in Cox-2 ΔSlco1c1 mice, preferentially in the more medial parts of the brain such as in the hypothalamic region, more rarely expressed Cox-2, while displaying extensive labeling for lipocalin-2 (Figure 6f ). This was in stark contrast to what was seen in WT mice, in which there was extensive co-expression of both proteins also in small vessels (Figure 6e ). Although there was some variation across animals, when a blinded investigator qualitatively determined the genotype of the animals by examining the degree of co-localization of Cox-2 and lipocalin-2 in differently sized vessels, the correct genotype was determined in 83 % of the animals (P = 0.0073; n = 13 for Cox-2 ΔSlco1c1 mice, and n = 9 for WT mice).
Restoration of PGE2 synthesis in the preoptic hypothalamus of mPGES-1 KO mice results in a temperature response to LPS
To determine if local PGE2 production in the hypothalamus results in a temperature response to LPS, we used intracerebral injection of a viral vector to restore the PGE2 synthesizing capacity in the median preoptic regions of mice with global deletion of mPGES-1, the inducible terminal PGE2 synthesizing enzyme (Jakobsson et al., 1999) . We chose to use mPGES-1 KO mice, which previously have been shown to be unable to mount a temperature rise upon peripheral immune challenge (Engblom et al., 2003; Nilsberth et al., 2009a ) instead of Cox-2 KO mice, because the latter are difficult to breed and suffer from various health problems, including chronic inflammations (Langenbach et al., 1999) . mPGES-1 KO mice with injections of viral vectors expressing GFP aimed at the region of the median preoptic nucleus, the structure critical for the fever response to PGE2 (Scammell et al., 1996; Lazarus et al., 2007) , displayed the same hypothermic response to immune challenge with LPS as shown previously for these mice (Engblom et al., 2003; Nilsberth et al., 2009a; Engström et al., 2012) . In contrast, mPGES-1 KO mice injected with a vector expressing mPGES-1 showed no sustained hypothermia after the initial temperature drop following the handling stress-induced temperature peak, but displayed a body temperature elevation compared to mice injected with a vector expressing GFP (Fig. 7a) . Mean body temperature during the period of 60 -480 min after LPS injection (i.e. after the handling stress induced temperature peak) was significantly different between treatments (F2,29 = 11.17, P = 0.0003; Lenti mPGES-1 vs Lenti GFP: P = 0.0042). While injection sites were determined by immunofluorescence to GFP (GFP lentiviral vector was added at 10 % to the mPGES-1 vector) (Fig. 7b) , transcription of mPGES-1 was assured by qPCR analysis. In a total of 8 mice injected with the viral vector expressing mPGES-1, all displayed mPGES-1 mRNA, whereas none of 4 mice injected with the GFP-vector did so, as expected.
Discussion
The febrile response is dependent on PGE2 synthesis by small to medium sized vessel in the hypothalamus, but independent of global PGE2 synthesis in brain
This study shows that the magnitude of the febrile response was strongly correlated with the PGE2 synthesizing capacity in the hypothalamus, as reflected in the levels of Cox-2 mRNA, but only weakly related to the PGE2 levels in cerebrospinal fluid. These findings were corroborated by the histological demonstration that genetic deletion of Cox-2 in brain endothelial cells using a tamoxifen inducible CreER T2 under the Slco1c1 promoter (Ridder et al., 2011) occurred preferentially in small to medium-sized vessels deep in the brain parenchyma, such as in the hypothalamus, whereas larger vessels, particularly those close to the neocortical surface, and vessels in the meninges were left unaffected. Accordingly, whereas the gene deletion attenuated the PGE2 synthesizing capacity in the hypothalamus, in which the EP3 receptor expressing neurons that are critical for the febrile response are located (Lazarus et al., 2007) , it left the PGE2 synthesis intact in large parts of the brain. Taken together, these data imply that the febrile response is dependent on the local, possibly paracrine release of PGE2 onto the preoptic EP3 receptor, whereas the overall PGE2 level in the brain, as reflected in the levels measured in the CSF, is not involved. This conclusion was further supported by the finding that local restoration of induced PGE2 synthesis in febrile resistant mPGES-1 KO mice at loci involving the median preoptic nucleus, the critical site for immune induced fever, resulted in a temperature elevation in response to ip LPS.
Previous findings that injection of PGE2 into the cerebral ventricles causes fever in a dose dependent manner (Engblom et al., 2003; Lazarus et al., 2007; Nilsberth et al., 2009b) could seem to indicate that PGE2 synthesized at some other site(s) in the brain than in the immediate vicinity of the preoptic EP3 receptor expressing neurons that are critical for the febrile response also could influence the firing properties of these neurons and hence elicit fever. However, as noted previously (Nilsberth et al., 2009b) , the concentration in the CSF of exogenously administered PGE2 that is required for eliciting fever is in the order of 1000-fold higher than that seen in CSF during immune-induced fever. This observation suggests that the concentration of PGE2 at its target neurons that is needed for eliciting fever in response to a peripheral immune stimulus is much higher than that measured in the CSF. It seems likely that such high concentrations of PGE2 during physiological conditions only could be achieved by paracrine release. This idea is supported by the demonstration that intracerebral injection of a threshold dose of PGE2 causes fever when localized to or in the immediate vicinity of the median preoptic nucleus, but not when localized to more distant sites (Scammell et al., 1996) . Similarly, microinjections of a cyclooxygenase inhibitor into the same area attenuated LPS-induced fever, whereas microinjections at other sites did not (Scammell et al., 1998) .
Relationship between fever and hypothermia
While injection of a viral vector encoding mPGES-1 resulted in a significantly higher body temperature after peripheral immune challenge than that displayed by mice subjected to control virus injections, the body temperature did not reach levels that could be classified as fever. The temperature response to immune challenge with LPS is likely the central compilation of pyrogenic and hypothermic signaling, the neuronal substrate being reciprocally interconnected cell groups that generate temperature elevating and temperature lowering signals, respectively (Zhao et al., 2017) . In the absence of induced PGE2 synthesis, animals immune challenged with LPS display hypothermia ( Fig. 7 ; see also Engström et al., 2012) , and such hypothermia occurs also in mice lacking EP3 receptors (Oishi et al., 2015) .
Hypothermia, which is elicited by a yet unidentified cryogen (Almeida et al., 2006) , is thus the response to LPS when no pyrogenic PGE2-EP3 signaling is present. While mPGES-1 KO mice, similar to WT mice, are fully responsive to intracerebroventricularly injected PGE2, hence demonstrating intact EP3 signaling (Engblom et al., 2003) , it should be noted that the response to the intracerebroventricularly injected PGE2 is graded. Low doses give rise to only a slight temperature elevation whereas high doses elicit a body temperature in the order of 40°C (Nilsberth et al., 2009) . The inability to fully restore the febrile response by virus vector injection in the present study is therefore likely explained by only partly restored PGE2
synthesis, which in turn may be due to incomplete mPGES-1 expression and/or deficient mPGES-1 protein coupling to Cox-2. The latter is induced in brain endothelial cells (Engström et al., 2012) , however structures that had incorporated the virus (and hence were shown to express GFP) were preferentially of neuron/glial cell type and were only rarely suggestive of endothelial cells (not shown). While speculative, mPGES-1 expressed by other cells than endothelial cells could perhaps couple with Cox-1 that is more ubiquitously expressed, hence resulting in PGE2 synthesis, although at levels that did not permit a fullfledged restoration of the febrile response. Never-the-less, the finding of a temperature elevation to LPS, although modest, in animals in which mPGES-1 was re-expressed in the preoptic region demonstrates the critical role for localized PGE2 synthesis for heat production in response to peripheral immune challenge.
Role of peripherally produced PGE2 for the febrile response
The present data confirm that prostaglandin production in brain endothelial cells is important for the febrile response (Engström et al., 2012; Wilhelms et al., 2014; Eskilsson et al., 2014a) .
However, it has been suggested that peripherally produced, circulating PGE2 also is involved , but data from mice chimeric for mPGES-1 imply that the role of PGE2 produced by hematopoietically derived cells is, at most, very small (Engström et al., 2012 ).
Here we found no significant relationship between the levels of PGE2 metabolites in plasma and PGE2 levels in the cerebrospinal fluid, suggesting that peripherally and centrally produced PGE2 are of distinct sources of origin, at least at the time point examined.
Accordingly, although there was a moderately strong relationship in the present study between the levels of PGE2 metabolites in plasma and the magnitude of fever, there is most likely no causality between these events; in the case of a strong peripheral immune response there is also a strong central immune response, and, conversely, a weak peripheral immune response is associated with a weak central immune response. This conclusion is supported by observations in the mice chimeric for mPGES-1. Thus, whereas WT mice carrying mPGES-1 KO hematopoietic cells displayed normal LPS induced fever, mPGES-1 KO mice carrying WT hematopoietic cells did not mount a febrile response, despite showing strong induction of PGE2 metabolites in plasma (Engström et al., 2012) . Furthermore, in those mice, central PGE2 levels were not significantly increased, providing additional support for the distinct origin of centrally and peripherally produced PGE2.
Heterogeneous distribution of transporter proteins among brain endothelial cells
We observed in the genetically modified mice that Cre recombinase expressed under the control of the Slco1c1 promoter produced recombination (and hence gene deletion) in brain endothelial cells in small and medium sized vessel but not in larger vessels. The Slco1c1 gene encodes the organic anion transporter 14 (Oatp14), which has been shown to be expressed selectively in endothelial cells of the brain (Ridder et al., 2011) . The organic anion transporter family transports hormones and other organic molecules to and from the brain (Westholm et al., 2008) , and it has been demonstrated that other members of the Oatp family also show heterogeneous distributions among the vessels in the brain similar to Oatp14, with the main expression being in smaller vessels (Daneman et al., 2010) . Furthermore, it has been shown that transporter proteins overall have a more prominent expression in capillaries than in venules (Macdonald et al., 2010) , which is consistent with the idea that the exchange of molecules and nutrients between blood and tissue occurs preferentially in the capillaries.
However, induced prostaglandin synthesis, as reflected by induced expression of Cox-2, seems to occur both in large, medium-sized and small vessels but not in capillaries (Fig. 5 ) (Eskilsson, 2014b) , and it is not yet known which transporter is responsible for the transfer of PGE2 into the brain. As shown here, PGE2 synthesis in small and medium-sized vessels is critical for the febrile response. The functional role of the PGE2 that is synthesized in the larger vessels, including vessels in meninges, and which seems to account for most of the PGE2 that is seen in the CSF, remains to be clarified. It has been reported recently that excitation of pyramidal cells in the cerebral cortex results in increased local cerebral blood flow via neuronal release of PGE2 and its binding to vasodilatory EP2 and EP4 receptors on vascular smooth muscle cells or pericytes (Lacroix et al., 2015) . Whether PGE2 produced by Temperature recordings from wild type (WT) and Cox-2 ΔSlco1c1 mice immune challenged by intraperitoneal injection of LPS (120 µg/kg). The initial temperature peak is due to the handling stress in conjunction with the injection procedure. It is prostaglandin independent (Saha et al., 2005) and does not differ between genotypes. b. Bar graph showing mean fever 5 h after LPS injection in WT type and Cox-2 ΔSlco1c1 mice. * indicates P < 0.05. In (a) and (b), n = 15 for WT LPS, n = 11 for Cox-2 ΔSlco1c1 LPS, n = 9 for WT NaCl, and n = 6 for Cox-2 ΔSlco1c1 NaCl. differ between WT and Cox-2 ΔSlco1c1 mice. In all graphs, n = 15 for WT LPS, n = 10-11 for Cox-2 ΔSlco1c1 LPS, n = 9-10 for WT NaCl, and n = 5-8 for Cox-2 ΔSlco1c1 NaCl. 
